17:00 - 19:00
A Paradigm Shift in Rheumatoid Arthritis -The Importance of Cytokine Blocking Treatment, Sponsored by Chugai Pharmaceutical Co., Ltd.
Room: ANA Crowne Plaza “Ohtori” Room B
Evening Symposium
Chair/s:
Tsutomu Takeuchi
Back
Pro-inflammatory cytokine therapy in rheumatoid arthritis and other inflammatory/autoimmune diseases.
John A. Hamilton
University of Melbourne, Department of Medicine at Royal Melbourne Hospital, Parkville, Australia

Rheumatoid arthritis (RA) is a chronic and systemic autoimmune disease with synovitis and progressive joint destruction as key features. Pro-inflammatory cytokines, such as tumor necrosis factor (TNF), interleukin-6 (IL-6) and others, are involved in the development of the disease.

The effects of these pro-inflammatory cytokine have been reported in some clinical trials and pre-clinical autoimmune/inflammation models. The most recent information on these topics is summarized.

Reference:
Tu-ES5-1
Session:
A Paradigm Shift in Rheumatoid Arthritis -The Importance of Cytokine Blocking Treatment, Sponsored by Chugai Pharmaceutical Co., Ltd.
Presenter/s:
John A. Hamilton
Presentation type:
Invited Speaker
Room:
ANA Crowne Plaza “Ohtori” Room B
Chair/s:
Tsutomu Takeuchi
Date:
Tuesday, 31 October 2017
Time:
17:00 - 17:40
Session times:
17:00 - 19:00
Back